Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:01 pm
| PEG Ratio | 4.82 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Infosys Ltd, a leading player in the IT Consulting & Software industry, reported a share price of ₹1,500 and a market capitalization of ₹6,23,243 Cr. In the financial year ending March 2025, the company recorded sales of ₹162,990 Cr, reflecting a steady growth trajectory from ₹146,767 Cr in March 2023. The sales figures for the recent quarters indicate a robust demand for Infosys’ services, with quarterly sales reaching ₹39,315 Cr in June 2024, and expected to touch ₹40,986 Cr by September 2024. This upward trend in sales has been consistent, showcasing the company’s resilience and adaptability in a competitive market. Furthermore, Infosys has successfully maintained an operating profit margin (OPM) of 24%, positioning itself favorably against typical sector benchmarks. The company’s revenue growth is complemented by a trailing twelve-month (TTM) revenue from operations of ₹165,954 Cr, underscoring its operational efficiency and market presence.
Profitability and Efficiency Metrics
Infosys demonstrated strong profitability metrics, with a net profit reported at ₹26,750 Cr for the fiscal year ending March 2025, an increase from ₹24,108 Cr in the previous year. The net profit margin stood at 16.41%, indicating effective cost management and pricing strategies. The company recorded a return on equity (ROE) of 27.87% and a return on capital employed (ROCE) of 35.85%, both significantly higher than typical industry averages, reflecting superior operational efficiency. Additionally, the interest coverage ratio (ICR) was robust at 102.97x, indicating that the company comfortably covers its interest obligations. This financial strength is further evidenced by a consistent operating profit margin of 24% across the reporting period. However, the cash conversion cycle (CCC) of 70 days may warrant attention, as a prolonged cycle can impact liquidity and operational agility.
Balance Sheet Strength and Financial Ratios
Infosys’ balance sheet exhibits considerable strength, with total assets standing at ₹147,795 Cr as of March 2025. The company reported reserves of ₹93,745 Cr and borrowings of ₹8,227 Cr, indicating a low debt-to-equity ratio, which enhances its financial stability. The price-to-book value (P/BV) ratio was recorded at 6.79x, suggesting that the market values the company at a premium relative to its net assets. Furthermore, the current ratio was a healthy 2.27, indicating robust short-term liquidity. The earnings yield of 4% and a dividend payout ratio of 75.97% reflect a commitment to returning value to shareholders while maintaining sufficient reinvestment for growth. Overall, the financial ratios signal a well-capitalized firm with a balanced approach to growth and shareholder returns.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Infosys reveals a diversified ownership structure, with Foreign Institutional Investors (FIIs) holding 31.92% and Domestic Institutional Investors (DIIs) holding 39.39% as of March 2025. This distribution indicates strong institutional confidence in the company’s strategic direction and financial health. Promoters hold a 14.61% stake, which has seen a gradual decline, raising questions about long-term commitment. Public shareholders account for 13.62%, showing a stable interest from retail investors. The total number of shareholders rose to 25,79,164, reflecting growing retail participation in the company’s equity. This diverse investor base can be interpreted as a positive sign of market confidence, although the declining promoter stake may trigger scrutiny regarding future governance and operational control.
Outlook, Risks, and Final Insight
Looking ahead, Infosys is positioned to leverage its operational strengths and market presence to drive further growth. However, potential risks include fluctuations in global demand for IT services and the impact of macroeconomic factors on client spending. Additionally, competition from both domestic and international players could pressure margins. Should Infosys successfully navigate these challenges, it could enhance its revenue streams and profitability metrics. Conversely, failure to adapt to market dynamics might hinder growth prospects. The company’s commitment to innovation and efficiency will be critical in maintaining its competitive edge. As Infosys continues to evolve, its ability to sustain profitability and shareholder returns while managing risks will define its long-term success in the IT consulting landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Infosys Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 2.78 Cr. | 185 | 185/93.8 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 11.9 Cr. | 20.2 | 20.2/14.4 | 7.82 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 33.5 Cr. | 78.8 | 91.6/16.7 | 31.6 | 5.69 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 15.7 Cr. | 54.2 | 70.7/33.1 | 8.78 | 56.5 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 30.1 Cr. | 87.5 | 221/72.2 | 41.2 | 12.7 | 1.14 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 116,060.81 Cr | 845.10 | 48.50 | 155.01 | 0.75% | 20.61% | 18.63% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34,470 | 36,538 | 38,318 | 37,441 | 37,933 | 38,994 | 38,821 | 37,923 | 39,315 | 40,986 | 41,764 | 40,925 | 42,279 |
| Expenses | 26,606 | 27,636 | 28,951 | 28,443 | 28,869 | 29,554 | 29,684 | 29,139 | 29,878 | 31,177 | 31,649 | 31,051 | 32,336 |
| Operating Profit | 7,864 | 8,902 | 9,367 | 8,998 | 9,064 | 9,440 | 9,137 | 8,784 | 9,437 | 9,809 | 10,115 | 9,874 | 9,943 |
| OPM % | 23% | 24% | 24% | 24% | 24% | 24% | 24% | 23% | 24% | 24% | 24% | 24% | 24% |
| Other Income | 676 | 584 | 769 | 671 | 561 | 632 | 789 | 2,729 | 838 | 712 | 859 | 1,190 | 1,042 |
| Interest | 56 | 66 | 80 | 82 | 90 | 138 | 131 | 110 | 105 | 108 | 101 | 102 | 105 |
| Depreciation | 950 | 1,029 | 1,125 | 1,121 | 1,173 | 1,166 | 1,176 | 1,163 | 1,149 | 1,160 | 1,203 | 1,299 | 1,140 |
| Profit before tax | 7,534 | 8,391 | 8,931 | 8,466 | 8,362 | 8,768 | 8,619 | 10,240 | 9,021 | 9,253 | 9,670 | 9,663 | 9,740 |
| Tax % | 29% | 28% | 26% | 28% | 29% | 29% | 29% | 22% | 29% | 30% | 29% | 27% | 29% |
| Net Profit | 5,362 | 6,026 | 6,586 | 6,134 | 5,945 | 6,215 | 6,113 | 7,975 | 6,374 | 6,516 | 6,822 | 7,038 | 6,924 |
| EPS in Rs | 12.74 | 14.31 | 15.70 | 14.77 | 14.32 | 14.97 | 14.71 | 19.20 | 15.34 | 15.67 | 16.39 | 16.93 | 16.66 |
Last Updated: August 2, 2025, 1:10 am
Below is a detailed analysis of the quarterly data for Infosys Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 42,279.00 Cr.. The value appears strong and on an upward trend. It has increased from 40,925.00 Cr. (Mar 2025) to 42,279.00 Cr., marking an increase of 1,354.00 Cr..
- For Expenses, as of Jun 2025, the value is 32,336.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31,051.00 Cr. (Mar 2025) to 32,336.00 Cr., marking an increase of 1,285.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 9,943.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,874.00 Cr. (Mar 2025) to 9,943.00 Cr., marking an increase of 69.00 Cr..
- For OPM %, as of Jun 2025, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.00%.
- For Other Income, as of Jun 2025, the value is 1,042.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,190.00 Cr. (Mar 2025) to 1,042.00 Cr., marking a decrease of 148.00 Cr..
- For Interest, as of Jun 2025, the value is 105.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 1,140.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,299.00 Cr. (Mar 2025) to 1,140.00 Cr., marking a decrease of 159.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 9,740.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,663.00 Cr. (Mar 2025) to 9,740.00 Cr., marking an increase of 77.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Mar 2025) to 29.00%, marking an increase of 2.00%.
- For Net Profit, as of Jun 2025, the value is 6,924.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,038.00 Cr. (Mar 2025) to 6,924.00 Cr., marking a decrease of 114.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.66. The value appears to be declining and may need further review. It has decreased from 16.93 (Mar 2025) to 16.66, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 4:16 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 50,133 | 53,319 | 62,441 | 68,484 | 70,522 | 82,675 | 90,791 | 100,472 | 121,641 | 146,767 | 153,670 | 162,990 | 165,954 |
| Expenses | 36,743 | 38,436 | 45,362 | 49,880 | 51,700 | 62,505 | 68,524 | 72,583 | 90,150 | 111,637 | 117,245 | 123,754 | 126,213 |
| Operating Profit | 13,390 | 14,883 | 17,079 | 18,604 | 18,822 | 20,170 | 22,267 | 27,889 | 31,491 | 35,130 | 36,425 | 39,236 | 39,741 |
| OPM % | 27% | 28% | 27% | 27% | 27% | 24% | 25% | 28% | 26% | 24% | 24% | 24% | 24% |
| Other Income | 2,664 | 3,430 | 3,120 | 3,050 | 3,311 | 2,882 | 2,803 | 2,201 | 2,295 | 2,701 | 4,711 | 3,600 | 3,803 |
| Interest | 9 | 12 | 0 | 0 | 0 | 0 | 170 | 195 | 200 | 284 | 470 | 416 | 416 |
| Depreciation | 1,317 | 1,017 | 1,459 | 1,703 | 1,863 | 2,011 | 2,893 | 3,267 | 3,476 | 4,225 | 4,678 | 4,812 | 4,802 |
| Profit before tax | 14,728 | 17,284 | 18,740 | 19,951 | 20,270 | 21,041 | 22,007 | 26,628 | 30,110 | 33,322 | 35,988 | 37,608 | 38,326 |
| Tax % | 28% | 28% | 28% | 28% | 21% | 27% | 24% | 27% | 26% | 28% | 27% | 29% | |
| Net Profit | 10,656 | 12,372 | 13,489 | 14,353 | 16,029 | 15,410 | 16,639 | 19,423 | 22,146 | 24,108 | 26,248 | 26,750 | 27,300 |
| EPS in Rs | 23.31 | 26.93 | 29.36 | 31.24 | 36.69 | 35.26 | 38.96 | 45.42 | 52.56 | 58.08 | 63.20 | 64.32 | 65.65 |
| Dividend Payout % | 34% | 55% | 41% | 41% | 59% | 60% | 45% | 59% | 59% | 58% | 73% | 67% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 16.10% | 9.03% | 6.41% | 11.68% | -3.86% | 7.98% | 16.73% | 14.02% | 8.86% | 8.88% | 1.91% |
| Change in YoY Net Profit Growth (%) | 0.00% | -7.08% | -2.62% | 5.27% | -15.54% | 11.84% | 8.76% | -2.71% | -5.16% | 0.02% | -6.96% |
Infosys Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 10% |
| 3 Years: | 0% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 30% |
| 3 Years: | 31% |
| Last Year: | 29% |
Last Updated: September 4, 2025, 9:40 pm
Balance Sheet
Last Updated: May 13, 2025, 3:59 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 286 | 572 | 1,144 | 1,144 | 1,088 | 2,170 | 2,122 | 2,124 | 2,098 | 2,069 | 2,071 | 2,073 |
| Reserves | 44,244 | 50,164 | 60,600 | 67,838 | 63,835 | 62,778 | 63,328 | 74,227 | 73,252 | 73,338 | 86,045 | 93,745 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 4,633 | 5,325 | 5,474 | 8,299 | 8,359 | 8,227 |
| Other Liabilities | 12,436 | 15,553 | 13,354 | 14,166 | 14,426 | 19,118 | 21,717 | 25,835 | 35,905 | 40,890 | 40,885 | 43,750 |
| Total Liabilities | 56,966 | 66,289 | 75,098 | 83,148 | 79,349 | 84,066 | 91,800 | 107,511 | 116,729 | 124,596 | 137,360 | 147,795 |
| Fixed Assets | 8,378 | 11,346 | 13,386 | 14,179 | 12,574 | 15,710 | 23,789 | 25,505 | 25,800 | 29,225 | 27,622 | 30,961 |
| CWIP | 961 | 776 | 960 | 1,365 | 1,606 | 1,388 | 954 | 922 | 416 | 288 | 293 | 814 |
| Investments | 4,331 | 2,270 | 1,892 | 16,423 | 12,163 | 11,261 | 8,792 | 14,205 | 20,324 | 19,478 | 24,623 | 23,541 |
| Other Assets | 43,296 | 51,897 | 58,860 | 51,181 | 53,006 | 55,707 | 58,265 | 66,879 | 70,189 | 75,605 | 84,822 | 92,479 |
| Total Assets | 56,966 | 66,289 | 75,098 | 83,148 | 79,349 | 84,066 | 91,800 | 107,511 | 116,729 | 124,596 | 137,360 | 147,795 |
Below is a detailed analysis of the balance sheet data for Infosys Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 2,073.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,071.00 Cr. (Mar 2024) to 2,073.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Mar 2025, the value is 93,745.00 Cr.. The value appears strong and on an upward trend. It has increased from 86,045.00 Cr. (Mar 2024) to 93,745.00 Cr., marking an increase of 7,700.00 Cr..
- For Borrowings, as of Mar 2025, the value is 8,227.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 8,359.00 Cr. (Mar 2024) to 8,227.00 Cr., marking a decrease of 132.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 43,750.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 40,885.00 Cr. (Mar 2024) to 43,750.00 Cr., marking an increase of 2,865.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 147,795.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 137,360.00 Cr. (Mar 2024) to 147,795.00 Cr., marking an increase of 10,435.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 30,961.00 Cr.. The value appears strong and on an upward trend. It has increased from 27,622.00 Cr. (Mar 2024) to 30,961.00 Cr., marking an increase of 3,339.00 Cr..
- For CWIP, as of Mar 2025, the value is 814.00 Cr.. The value appears strong and on an upward trend. It has increased from 293.00 Cr. (Mar 2024) to 814.00 Cr., marking an increase of 521.00 Cr..
- For Investments, as of Mar 2025, the value is 23,541.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24,623.00 Cr. (Mar 2024) to 23,541.00 Cr., marking a decrease of 1,082.00 Cr..
- For Other Assets, as of Mar 2025, the value is 92,479.00 Cr.. The value appears strong and on an upward trend. It has increased from 84,822.00 Cr. (Mar 2024) to 92,479.00 Cr., marking an increase of 7,657.00 Cr..
- For Total Assets, as of Mar 2025, the value is 147,795.00 Cr.. The value appears strong and on an upward trend. It has increased from 137,360.00 Cr. (Mar 2024) to 147,795.00 Cr., marking an increase of 10,435.00 Cr..
Notably, the Reserves (93,745.00 Cr.) exceed the Borrowings (8,227.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 13.00 | 14.00 | 17.00 | 18.00 | 18.00 | 20.00 | 18.00 | 22.00 | 26.00 | 27.00 | 28.00 | 31.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 66 | 66 | 66 | 68 | 65 | 74 | 70 | 68 | 63 | 72 | 70 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 61 | 66 | 66 | 66 | 68 | 65 | 74 | 70 | 68 | 63 | 72 | 70 |
| Working Capital Days | 15 | 3 | 34 | 38 | 50 | 36 | 42 | 36 | 28 | 31 | 54 | 39 |
| ROCE % | 36% | 36% | 33% | 30% | 30% | 32% | 32% | 35% | 37% | 40% | 40% | 38% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Nifty 50 ETF | 66,107,395 | 5.82 | 12399.1 | 66,107,395 | 2025-04-22 16:13:51 | 0% |
| SBI BSE Sensex ETF | 47,836,403 | 6.97 | 8974.11 | 47,836,403 | 2025-04-22 16:13:51 | 0% |
| UTI Nifty 50 ETF | 19,345,046 | 5.82 | 3628.36 | 19,345,046 | 2025-04-22 16:13:51 | 0% |
| UTI BSE Sensex ETF | 17,836,375 | 6.97 | 3346.1 | 17,836,375 | 2025-04-22 16:13:51 | 0% |
| ICICI Prudential Value Discovery Fund | 17,820,578 | 6.53 | 3342.43 | 17,820,578 | 2025-04-22 16:13:51 | 0% |
| ICICI Prudential Technology Fund | 17,580,044 | 23.26 | 3297.31 | 17,580,044 | 2025-04-22 16:13:51 | 0% |
| ICICI Prudential Bluechip Fund | 16,770,859 | 4.75 | 3145.54 | 16,770,859 | 2025-04-22 16:13:51 | 0% |
| Mirae Asset Large Cap Fund | 13,973,661 | 6.21 | 2620.9 | 13,973,661 | 2025-04-22 16:13:51 | 0% |
| SBI Blue Chip Fund | 13,700,000 | 4.82 | 2569.57 | 13,700,000 | 2025-04-22 16:13:51 | 0% |
| HDFC Balanced Advantage Fund - Regular Plan | 13,314,298 | 2.59 | 2497.23 | 13,314,298 | 2025-04-22 16:13:51 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | 64.50 | 63.39 | 57.63 | 52.52 | 45.61 |
| Diluted EPS (Rs.) | 64.34 | 63.39 | 57.54 | 52.41 | 45.52 |
| Cash EPS (Rs.) | 76.13 | 74.66 | 68.47 | 61.06 | 53.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 231.11 | 212.74 | 183.17 | 180.50 | 180.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 231.11 | 212.74 | 183.17 | 180.50 | 180.75 |
| Revenue From Operations / Share (Rs.) | 393.13 | 371.00 | 354.68 | 289.90 | 236.52 |
| PBDIT / Share (Rs.) | 103.32 | 99.31 | 91.42 | 80.52 | 70.83 |
| PBIT / Share (Rs.) | 91.71 | 88.02 | 81.21 | 72.23 | 63.14 |
| PBT / Share (Rs.) | 90.71 | 86.89 | 80.53 | 71.76 | 62.68 |
| Net Profit / Share (Rs.) | 64.52 | 63.37 | 58.26 | 52.78 | 45.72 |
| NP After MI And SOA / Share (Rs.) | 64.43 | 63.33 | 58.23 | 52.69 | 45.55 |
| PBDIT Margin (%) | 26.28 | 26.76 | 25.77 | 27.77 | 29.94 |
| PBIT Margin (%) | 23.32 | 23.72 | 22.89 | 24.91 | 26.69 |
| PBT Margin (%) | 23.07 | 23.41 | 22.70 | 24.75 | 26.50 |
| Net Profit Margin (%) | 16.41 | 17.08 | 16.42 | 18.20 | 19.33 |
| NP After MI And SOA Margin (%) | 16.38 | 17.07 | 16.41 | 18.17 | 19.26 |
| Return on Networth / Equity (%) | 27.87 | 29.77 | 31.95 | 29.34 | 25.34 |
| Return on Capital Employeed (%) | 35.85 | 36.81 | 38.79 | 35.96 | 31.73 |
| Return On Assets (%) | 17.93 | 19.03 | 19.15 | 18.75 | 17.85 |
| Asset Turnover Ratio (%) | 1.14 | 1.17 | 1.20 | 1.08 | 0.92 |
| Current Ratio (X) | 2.27 | 2.31 | 1.81 | 2.00 | 2.54 |
| Quick Ratio (X) | 2.27 | 2.31 | 1.81 | 2.00 | 2.54 |
| Dividend Payout Ratio (NP) (%) | 75.97 | 56.00 | 56.57 | 57.23 | 47.12 |
| Dividend Payout Ratio (CP) (%) | 64.37 | 47.53 | 48.13 | 49.46 | 40.32 |
| Earning Retention Ratio (%) | 24.03 | 44.00 | 43.43 | 42.77 | 52.88 |
| Cash Earning Retention Ratio (%) | 35.63 | 52.47 | 51.87 | 50.54 | 59.68 |
| Interest Coverage Ratio (X) | 102.97 | 87.52 | 133.21 | 168.93 | 154.31 |
| Interest Coverage Ratio (Post Tax) (X) | 65.30 | 56.85 | 85.89 | 111.73 | 100.61 |
| Enterprise Value (Cr.) | 627017.84 | 606361.96 | 578997.26 | 783175.12 | 556737.20 |
| EV / Net Operating Revenue (X) | 3.85 | 3.95 | 3.94 | 6.44 | 5.54 |
| EV / EBITDA (X) | 14.64 | 14.74 | 15.30 | 23.18 | 18.50 |
| MarketCap / Net Operating Revenue (X) | 3.99 | 4.04 | 4.03 | 6.58 | 5.78 |
| Retention Ratios (%) | 24.02 | 43.99 | 43.42 | 42.76 | 52.87 |
| Price / BV (X) | 6.79 | 7.05 | 7.83 | 10.62 | 7.61 |
| Price / Net Operating Revenue (X) | 3.99 | 4.04 | 4.03 | 6.58 | 5.78 |
| EarningsYield | 0.04 | 0.04 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Infosys Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 64.50. This value is within the healthy range. It has increased from 63.39 (Mar 24) to 64.50, marking an increase of 1.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is 64.34. This value is within the healthy range. It has increased from 63.39 (Mar 24) to 64.34, marking an increase of 0.95.
- For Cash EPS (Rs.), as of Mar 25, the value is 76.13. This value is within the healthy range. It has increased from 74.66 (Mar 24) to 76.13, marking an increase of 1.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.11. It has increased from 212.74 (Mar 24) to 231.11, marking an increase of 18.37.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 231.11. It has increased from 212.74 (Mar 24) to 231.11, marking an increase of 18.37.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 393.13. It has increased from 371.00 (Mar 24) to 393.13, marking an increase of 22.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 103.32. This value is within the healthy range. It has increased from 99.31 (Mar 24) to 103.32, marking an increase of 4.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.71. This value is within the healthy range. It has increased from 88.02 (Mar 24) to 91.71, marking an increase of 3.69.
- For PBT / Share (Rs.), as of Mar 25, the value is 90.71. This value is within the healthy range. It has increased from 86.89 (Mar 24) to 90.71, marking an increase of 3.82.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 64.52. This value is within the healthy range. It has increased from 63.37 (Mar 24) to 64.52, marking an increase of 1.15.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 64.43. This value is within the healthy range. It has increased from 63.33 (Mar 24) to 64.43, marking an increase of 1.10.
- For PBDIT Margin (%), as of Mar 25, the value is 26.28. This value is within the healthy range. It has decreased from 26.76 (Mar 24) to 26.28, marking a decrease of 0.48.
- For PBIT Margin (%), as of Mar 25, the value is 23.32. This value exceeds the healthy maximum of 20. It has decreased from 23.72 (Mar 24) to 23.32, marking a decrease of 0.40.
- For PBT Margin (%), as of Mar 25, the value is 23.07. This value is within the healthy range. It has decreased from 23.41 (Mar 24) to 23.07, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 25, the value is 16.41. This value exceeds the healthy maximum of 10. It has decreased from 17.08 (Mar 24) to 16.41, marking a decrease of 0.67.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.38. This value is within the healthy range. It has decreased from 17.07 (Mar 24) to 16.38, marking a decrease of 0.69.
- For Return on Networth / Equity (%), as of Mar 25, the value is 27.87. This value is within the healthy range. It has decreased from 29.77 (Mar 24) to 27.87, marking a decrease of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 35.85. This value is within the healthy range. It has decreased from 36.81 (Mar 24) to 35.85, marking a decrease of 0.96.
- For Return On Assets (%), as of Mar 25, the value is 17.93. This value is within the healthy range. It has decreased from 19.03 (Mar 24) to 17.93, marking a decrease of 1.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.17 (Mar 24) to 1.14, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 2.27. This value is within the healthy range. It has decreased from 2.31 (Mar 24) to 2.27, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 2.27. This value exceeds the healthy maximum of 2. It has decreased from 2.31 (Mar 24) to 2.27, marking a decrease of 0.04.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.97. This value exceeds the healthy maximum of 50. It has increased from 56.00 (Mar 24) to 75.97, marking an increase of 19.97.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 64.37. This value exceeds the healthy maximum of 50. It has increased from 47.53 (Mar 24) to 64.37, marking an increase of 16.84.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.03. This value is below the healthy minimum of 40. It has decreased from 44.00 (Mar 24) to 24.03, marking a decrease of 19.97.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 35.63. This value is below the healthy minimum of 40. It has decreased from 52.47 (Mar 24) to 35.63, marking a decrease of 16.84.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 102.97. This value is within the healthy range. It has increased from 87.52 (Mar 24) to 102.97, marking an increase of 15.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 65.30. This value is within the healthy range. It has increased from 56.85 (Mar 24) to 65.30, marking an increase of 8.45.
- For Enterprise Value (Cr.), as of Mar 25, the value is 627,017.84. It has increased from 606,361.96 (Mar 24) to 627,017.84, marking an increase of 20,655.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.85. This value exceeds the healthy maximum of 3. It has decreased from 3.95 (Mar 24) to 3.85, marking a decrease of 0.10.
- For EV / EBITDA (X), as of Mar 25, the value is 14.64. This value is within the healthy range. It has decreased from 14.74 (Mar 24) to 14.64, marking a decrease of 0.10.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.99. This value exceeds the healthy maximum of 3. It has decreased from 4.04 (Mar 24) to 3.99, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 24.02. This value is below the healthy minimum of 30. It has decreased from 43.99 (Mar 24) to 24.02, marking a decrease of 19.97.
- For Price / BV (X), as of Mar 25, the value is 6.79. This value exceeds the healthy maximum of 3. It has decreased from 7.05 (Mar 24) to 6.79, marking a decrease of 0.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.99. This value exceeds the healthy maximum of 3. It has decreased from 4.04 (Mar 24) to 3.99, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Infosys Ltd:
- Net Profit Margin: 16.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 35.85% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 27.87% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 65.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21.9 (Industry average Stock P/E: 48.5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | No. 44, Hosur Road, Electronics City, Bengaluru Karnataka 560100 | investors@infosys.com http://www.infosys.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Nandan M Nilekani | Chairman (Non - Executive) & Non Independent Direc |
| Mr. Salil Parekh | Managing Director & CEO |
| Mr. D Sundaram | Lead Independent Director |
| Mr. Michael Gibbs | Independent Director |
| Mr. Govind Iyer | Independent Director |
| Ms. Chitra Nayak | Independent Director |
| Mr. Bobby Parikh | Independent Director |
| Ms. Helene Auriol Potier | Independent Director |
| Mr. Nitin Paranjpe | Independent Director |
FAQ
What is the intrinsic value of Infosys Ltd?
Infosys Ltd's intrinsic value (as of 03 November 2025) is 1292.70 which is 13.01% lower the current market price of 1,486.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 6,17,053 Cr. market cap, FY2025-2026 high/low of 2,007/1,307, reserves of ₹93,745 Cr, and liabilities of 147,795 Cr.
What is the Market Cap of Infosys Ltd?
The Market Cap of Infosys Ltd is 6,17,053 Cr..
What is the current Stock Price of Infosys Ltd as on 03 November 2025?
The current stock price of Infosys Ltd as on 03 November 2025 is 1,486.
What is the High / Low of Infosys Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Infosys Ltd stocks is 2,007/1,307.
What is the Stock P/E of Infosys Ltd?
The Stock P/E of Infosys Ltd is 21.9.
What is the Book Value of Infosys Ltd?
The Book Value of Infosys Ltd is 249.
What is the Dividend Yield of Infosys Ltd?
The Dividend Yield of Infosys Ltd is 2.89 %.
What is the ROCE of Infosys Ltd?
The ROCE of Infosys Ltd is 37.5 %.
What is the ROE of Infosys Ltd?
The ROE of Infosys Ltd is 28.8 %.
What is the Face Value of Infosys Ltd?
The Face Value of Infosys Ltd is 5.00.
